The $800 Million Pill: The Truth Behind the Cost of New Drugs

Valutazione media 3,71
( su 56 valutazioni fornite da GoodReads )
 
9780520246706: The $800 Million Pill: The Truth Behind the Cost of New Drugs

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping expose, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Goozner, Merrill
Editore: University of California Press
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi PAPERBACK Quantità: 1
Da
Skymedia
(PLANTATION, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of California Press. PAPERBACK. Condizione libro: New. 0520246705 New Book, may have some minor shelf wear. Fast Shipping, Excellent Customer Service, Satisfaction Guaranteed. Codice libro della libreria B-5-608

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 4,66
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,66
In U.S.A.
Destinazione, tempi e costi

2.

Merrill Goozner
Editore: University of California Press (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of California Press, 2005. Paperback. Condizione libro: New. 1. Codice libro della libreria DADAX0520246705

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 10,38
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,72
In U.S.A.
Destinazione, tempi e costi

3.

Merrill Goozner
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Quantità: 1
Da
Castle Rock
(Pittsford, NY, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Condizione libro: Brand New. Book Condition: Brand New. Codice libro della libreria 97805202467061.0

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 14,13
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,72
In U.S.A.
Destinazione, tempi e costi

4.

Merrill Goozner
Editore: University of California Press, United States (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro University of California Press, United States, 2005. Paperback. Condizione libro: New. 223 x 147 mm. Language: English . Brand New Book. Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping expose, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The $800 Million Pill suggests ways that the government s role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Codice libro della libreria AAH9780520246706

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 23,15
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Merrill Goozner
Editore: University of California Press, United States (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro University of California Press, United States, 2005. Paperback. Condizione libro: New. 223 x 147 mm. Language: English . Brand New Book. Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping expose, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The $800 Million Pill suggests ways that the government s role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Codice libro della libreria AAH9780520246706

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 23,16
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Goozner, Merrill
Editore: University of California Press (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of California Press, 2005. Paperback. Condizione libro: New. book. Codice libro della libreria 0520246705

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 26,57
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

7.

Merrill Goozner
Editore: University of California Press
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 5
Da
THE SAINT BOOKSTORE
(Southport, Regno Unito)
Valutazione libreria
[?]

Descrizione libro University of California Press. Paperback. Condizione libro: new. BRAND NEW, The $800 Million Pill: The Truth Behind the Cost of New Drugs, Merrill Goozner, Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping expose, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Codice libro della libreria B9780520246706

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 20,91
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,10
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Merrill Goozner
Editore: University of California Press (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Quantità: 2
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro University of California Press, 2005. PAP. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria WF-9780520246706

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 17,27
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,75
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

9.

Goozner, Merrill
Editore: University of California Press (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 3
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of California Press, 2005. Paperback. Condizione libro: New. Codice libro della libreria P110520246705

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 25,90
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,79
In U.S.A.
Destinazione, tempi e costi

10.

Goozner, Merrill
Editore: University of California Press (2005)
ISBN 10: 0520246705 ISBN 13: 9780520246706
Nuovi Paperback Quantità: 10
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of California Press, 2005. Paperback. Condizione libro: New. Codice libro della libreria INGM9780520246706

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 31,16
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,72
In U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro